0001104659-23-117704.txt : 20231114 0001104659-23-117704.hdr.sgml : 20231114 20231114080020 ACCESSION NUMBER: 0001104659-23-117704 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231107 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Century Therapeutics, Inc. CENTRAL INDEX KEY: 0001850119 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842040295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40498 FILM NUMBER: 231401652 BUSINESS ADDRESS: STREET 1: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-981-4000 MAIL ADDRESS: STREET 1: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 8-K 1 tm2330591d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 7, 2023

Century Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40498		84-2040295
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

3675 Market Street

Philadelphia, Pennsylvania

19104

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (267) 817-5790

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Exchange on Which Registered
Common Stock, par value $0.0001 per share		IPSC		Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Chief Executive Officer

On November 7, 2023, the Board of Directors (the “Board”) of Century Therapeutic, Inc. (the “Company”) appointed Brent Pfeiffenberger to serve as the Company’s President and Chief Executive Officer, effective December 4, 2023 (the “Effective Date”). Concurrently with his appointment as President and Chief Executive Officer and effective as of the Effective Date, Dr. Pfeiffenberger was appointed to serve as a member of the Board and the size of the Board will increase to eight directors. As of the Effective Date, Dr. Pfeiffenberger will serve as the Company’s principal executive officer, succeeding Gregory Russotti, who will continue to serve as the Company’s interim President and Chief Executive Officer through the Effective Date. As of the Effective Date, Dr. Russotti will serve as the Company’s Chief Technology and Manufacturing Officer.

Dr. Pfeiffenberger, age 46, has served as Chief Operating Officer of Neogene Therapeutics Inc., a clinical-stage biotechnology company since May 2021. Prior to this, Dr. Pfeiffenberger held various positions at Bristol Myers Squibb Company, a global biopharmaceutical company, including Senior Vice President and Head of U.S. Oncology from October 2019 until May 2021; Co-Lead of Worldwide Commercial Oncology from July 2018 until October 2019; General Manager for Australia and New Zealand from March 2016 until June 2018; and several additional leadership and managerial positions within Bristol Myers Squibb Company prior to this. Dr. Pfeiffenberger holds an M.B.A. from The Wharton School at the University of Pennsylvania and a Pharm.D. from Duquesne University. The Board believes that Dr. Pfeiffenberger’s over 20 years of global biopharmaceutical and biotechnology experience provide him with the qualifications and skills to serve as a director.

In connection with Dr. Pfeiffenberger’s appointment as the Company’s President and Chief Executive Officer, the Company and Dr. Pfeiffenberger entered into an employment agreement on November 7, 2023 (the “Agreement”). Pursuant to the Agreement, which is effective as of the Effective Date, Dr. Pfeiffenberger is entitled to (i) an annual base salary of $625,000, (ii) an annual performance-based target bonus of 55% of his annual base salary, (iii) a one-time signing bonus of $200,000, (iv) a one-time retention bonus of $450,000, and an equity award consisting of (a) an option to purchase 573,691 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) at an exercise price equal to the closing price of the Common Stock on the date of grant (the “Option”), (b) restricted stock units covering 1,173,775 shares of Common Stock (the “Initial RSU Award”) and (c) restricted stock units with a value of at least $450,000 (the “Second RSU Award”). The Option, First RSU Award and Second RSU Award will be granted to Dr. Pfeiffenberger under the Company’s 2021 Equity Incentive Plan (the “Plan”). In addition, the Company will reimburse Dr. Pfeiffenberger up to $150,000 for reasonable expenses incurred in connection with Dr. Pfeiffenberger’s relocation to the Philadelphia, Pennsylvania.

The Option will vest 25% on the first anniversary of the later of the date of grant and the date Dr. Pfeiffenberger begins employment with the Company (the “Initial Vesting Date”), with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to Dr. Pfeiffenberger’s continued employment with the Company and subject to the terms of the Plan. The Initial RSU Award will vest 25% on the Initial Vesting Date, and the remaining 75% in one-twelfth (1/12th) increments on each of the first trading days on or after each of February 15, May 15, August 15, and November 15, until the First RSU is fully vested, subject to Dr. Pfeiffenberger’s continued employment with the Company and subject to the terms of the Plan. The Second RSU Award shall vest 100% on the Initial Vesting Date, subject to Dr. Pfeiffenberger’s continued employment with the Company and subject to the terms of the Plan.

Upon a termination of Dr. Pfeiffenberger’s employment without “cause” (as defined in the Agreement) by the Company or resignation for “good reason” (as defined in the Agreement), Dr. Pfeiffenberger is entitled to receive (i) payment of all accrued and unpaid base salary, (ii) payment of any otherwise earned but unpaid annual bonus for the prior year, (iii) payment of pro-rata bonus for the year of termination, and (iv) continuation of his base salary and COBRA premiums paid by us for twelve (12) months. In addition, if such termination without cause or for good reason occurs within the three (3) month period prior to or the twelve (12) month period immediately following a change in control, then Dr. Pfeiffenberger’s salary and COBRA continuation period will be extended from twelve (12) months to eighteen (18) months, and he will receive a lump sum payment in an amount equal to his target annual bonus for the calendar year in which the termination occurs, and all outstanding equity awards subject to vesting solely based on the passage of time and Dr. Pfeiffenberger’s continued employment will become vested on the later of Dr. Pfeiffenberger’s termination date and the change in control.

Upon a termination of Dr. Pfeiffenberger for any reason other than without cause or resignation for good reason, including, but not limited to (i) termination for cause, (ii) resignation without good reason, (iii) termination as a result of Dr. Pfeiffenberger’s “disability” (as defined in the Agreement) or death, then the Company’s obligation to Dr. Pfeiffenberger will be limited solely to the payment of accrued and unpaid base salary through the date of such termination of employment. All other compensation and benefits will cease at the time of such termination, except as otherwise provided by COBRA.

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which will be filed as an exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

In addition, Dr. Pfeiffenberger will enter into an indemnification agreement with the Company, which provides for the indemnification of Dr. Pfeiffenberger for certain expenses, including attorneys’ fees, judgments, penalties, fines, and settlement amounts incurred by Dr. Pfeiffenberger in any action or proceeding arising out of his service to the Company as Chief Executive Officer or director. Dr. Pfeiffenberger has also entered into a proprietary information and assignment agreement with the Company, which includes customary provisions regarding confidentiality and ownership of intellectual property and certain prohibitions against competition with the Company and solicitation of the Company’s customers and employees, both during employment and for one year following any cessation of employment.

There are no arrangements or understandings between Dr. Pfeiffenberger and any other persons pursuant to which Dr. Pfeiffenberger was appointed as Chief Executive Officer of the Company. In addition, there are no family relationships between Dr. Pfeiffenberger and any director or executive officer of the Company, and there are no transactions involving Dr. Pfeiffenberger requiring disclosure under Item 404(a) of Regulation S-K.

In connection with the appointment of Dr. Pfeiffenberger, on November 7, 2023, the Board appointed Gregory Russotti, Ph.D., the Company’s current interim President and Chief Executive Officer, to serve as the Company’s Chief Technology and Manufacturing Officer, effective as of the Effective Date. Dr. Russotti has served as the Company’s interim President and Chief Executive Officer since April 2023 and is party to an Executive Employment Agreement with the Company, dated as of May 26, 2021, filed as Exhibit 10.35 to the Company’s Registration Statement on Form S-1, filed on May 28, 2021 (the “Employment Agreement”) and a Side Letter to Executive Employment Agreement with the Company, dated as of April 12, 2023, filed as Exhibit 10.1 to the Company’s Periodic Report on Form 8-K filed on April 17, 2023 (the “Side Letter”). All terms of the Employment Agreement remain unmodified and in full force and effect. The Side Letter will terminate pursuant to its terms on the Effective Date.

In connection with Dr. Russotti’s appointment to Chief Technology and Manufacturing Officer, the Board approved a base salary in the amount of $525,000, with an annual target bonus percentage of 45%, to be effective as of the Effective Date.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CENTURY THERAPEUTICS, INC.

	By:	/s/ Gregory Russotti, Ph.D.
	Name:	Gregory Russotti, Ph.D.
	Title:	Interim President and Chief Executive Officer

Date: November 14, 2023

EX-101.SCH 2 ipsc-20231107.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 ipsc-20231107_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 ipsc-20231107_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT

Cover	Nov. 07, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 07, 2023
Entity File Number	001-40498
Entity Registrant Name	Century Therapeutics, Inc.
Entity Central Index Key	0001850119
Entity Tax Identification Number	84-2040295
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	3675 Market Street
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19104
City Area Code	267
Local Phone Number	817-5790
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	IPSC
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 6 tm2330591d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001850119 2023-11-07 2023-11-07 iso4217:USD shares iso4217:USD shares false 0001850119 8-K 2023-11-07 Century Therapeutics, Inc. DE 001-40498 84-2040295 3675 Market Street Philadelphia PA 19104 267 817-5790 false false false false Common Stock, par value $0.0001 per share IPSC NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://centurytx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ipsc-20231107.xsd ipsc-20231107_lab.xml ipsc-20231107_pre.xml tm2330591d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2330591d1_8k.htm": { "nsprefix": "IPSC", "nsuri": "http://centurytx.com/20231107", "dts": { "schema": { "local": [ "ipsc-20231107.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ipsc-20231107_lab.xml" ] }, "presentationLink": { "local": [ "ipsc-20231107_pre.xml" ] }, "inline": { "local": [ "tm2330591d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://centurytx.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2330591d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2330591d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://centurytx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001104659-23-117704-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-117704-xbrl.zip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end